In a similar report, Lee and colleagues showed that previous infection in octogenarians followed by two doses of BNT162b2 about 1.5 years later resulted in a strong neutralisation based on an ACE2 binding inhibition assay against omicron variant, when compared to persons who had only received two BNT162b2 doses.95 Here, ACE2 is linked to infection.